Corpus Intelligence IC Memo — RANGE REGIONAL HEALTH SERVICES 2026-04-26 06:40 UTC
IC Memo — RANGE REGIONAL HEALTH SERVICES
Investment Committee Memorandum | MN | 72 beds | Grade C | EBITDA uplift $8.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

RANGE REGIONAL HEALTH SERVICES

CCN 240040 | ST. LOUIS, MN | 72 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

RANGE REGIONAL HEALTH SERVICES is a 72-bed suburban community hospital in ST. LOUIS, MN with $121.0M in net patient revenue and a -10.3% operating margin. The hospital serves a payer mix of 28.8% Medicare, 9.4% Medicaid, and 61.8% commercial.

Thesis: Turnaround. Our ML models identify $8.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.3% to -3.0% (+736bps).

Net Revenue HCRIS$121.0M
Current EBITDA COMPUTED$-12.5M
Operating Margin COMPUTED-10.3%
Occupancy HCRIS51.6%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS35.2%
Distress Probability ML48.9%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
26
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -10.3% places it below the state median. Among 26 size-comparable peers (36-144 beds), the median margin is -5.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-144), prioritizing same-state peers. 26 hospitals in the comp set.

HospitalStateBedsRevenueMargin
RANGE REGIONAL HEALTH SERVICES (Target)MN72$121.0M-10.3%
SMDC MEDICAL CENTERMN118$519.2M-7.1%
MCHS - SOUTHWEST MINNESOTA REGMN118$473.6M-9.8%
LAKEVIEW MEMORIALMN68$411.9M60.9%
SANFORD BEMIDJIMN94$312.6M-19.6%
RIDGEVIEW MEDICAL CENTERMN109$287.8M-14.2%
ST. JOSEPHS MEDICAL CENTERMN127$283.3M-0.0%
MAYO CLNIC HLTH SYS-ALBRT LEA MN79$271.9M-16.6%
GILLETTE CHILDRENS SPECIALTY HMN60$266.7M-6.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.5M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$77K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.5M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$77K
Total EBITDA Uplift$8.9M
Current EBITDA$-12.5M
+ RCM Uplift+$8.9M
Pro Forma EBITDA$-3.6M
Current Margin-10.3%
Pro Forma Margin-3.0%
WC Released (1x)$4.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-19.2M$6.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-19.2M$1.2M0.00x-100.0%
Bull Case9.0x11.0x$-17.3M$24.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-17.3M$21.4M0.00x-100.0%
Bear Case11.0x10.0x$-21.1M$-31.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-21.1M$-41.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 26 hospitals with 36-144 beds
  • Same-state prioritization (n=27)
  • Comp margins: P25=-9.8% / P50=-5.5% / P75=-0.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.